Clinical trial
Continuous Cellsaver and Neurocognitive Decline Post Cardiac Surgery
NCT00296985 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00296985 |
|---|---|
| Title | Continuous Cellsaver and Neurocognitive Decline Post Cardiac Surgery |
| Official title | The Impact of Continuous Flow Cellsaver on Neurocognitive Decline After Cardiac Surgery |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Heart and Stroke Foundation of Ontario |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart Disease, Neurocognitive Decline |
| Intervention type | Device |
| Interventions | Fresenius Cellsaver |
| Enrollment | 312 |
| Start date | Dec 1, 2001 |
| Primary completion | Jan 1, 2005 |
| Completion | Jan 1, 2007 |
| First posted | Feb 27, 2006 |
| Last update posted | Nov 27, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: